{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import openai\n",
    "import json\n",
    "import pandas as pd\n",
    "from transformers import GPT2TokenizerFast"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "openai authentication"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# openai.organization = \"org-iKrZv1G3h27ngg6tO3rkCDlk\" mine \n",
    "openai.organization = \"org-us16wmNswbfs7htSVY2eiaYh\" # zazu\n",
    "# openai.api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "# openai.api_key = \"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\" mine \n",
    "openai.api_key = \"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\" # zazu"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "read in the protocol in csv format and convert to string"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "data = pd.read_csv('text/clinical_trial_rank_0131/text.csv')\n",
    "# data = pd.read_csv('cut_trial0061.csv')\n",
    "text = data.astype(str)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## check how much it will cost to process"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "tokenizer = GPT2TokenizerFast.from_pretrained(\"gpt2\")"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Chunks"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Cut the document into chunks.\n",
    "1. Start with question\n",
    "2. Keep adding until we get 3500 tokens\n",
    "3. Send the chunk to API"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "# question = \"\"\"Extract the validated clinical questionnaires used in this text in a comma separated list with each questionnaire on a new line:\n",
    "# example text: nation', 'EMA', 'European Medicines Agency', 'DLQI', 'Dermatology Life Quality Index', 'EQ-5D', 'European Quality of Life 5-Dimension Questionnaire', 'FCBP', 'Females of childbearing potential', 'FDA', 'Food and Drug Administration'\n",
    "# example answer: \n",
    "# - EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
    "# - DLQI, Dermatology Life Quality Index\n",
    "# \"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "# question = \"\"\"Extract the validated clinical questionnaires used in this text with a dash, long name and short name in brackets like so:\n",
    "# - Patient Benefit Index, (PBI)\n",
    "# - European Quality of Life 5-Dimension Questionnaire, (EQ-5D)\n",
    "# \"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "question = \"\"\"Extract the validated clinical questionnaires used in this text in a comma separated list with each questionnaire on a new line:\n",
    "example text: nation', 'EMA', 'European Medicines Agency', 'DLQI', 'Dermatology Life Quality Index', 'EQ-5D', 'European Quality of Life 5-Dimension Questionnaire', 'FCBP', 'Females of childbearing potential', 'FDA', 'Food and Drug Administration'\n",
    "example answer: \n",
    "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
    "- DLQI, Dermatology Life Quality Index\n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Token indices sequence length is longer than the specified maximum sequence length for this model (1497 > 1024). Running this sequence through the model will result in indexing errors\n"
     ]
    }
   ],
   "source": [
    "chunks = []\n",
    "page = 0\n",
    "\n",
    "chunk_tokens = 0\n",
    "chunk = question\n",
    "\n",
    "\n",
    "while page < len(text):\n",
    "    page_count = 0\n",
    "    chunk_tokens = 0\n",
    "    chunk = question\n",
    "    while chunk_tokens <= 3500 and page_count < 5 and page < len(text):\n",
    "        chunk += text.iloc[page][2]\n",
    "        chunk_tokens += len(tokenizer(chunk)[0])\n",
    "        page += 1\n",
    "        page_count += 1\n",
    "    chunks.append(chunk)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### ChatGPT API\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "answers = []\n",
    "for chunk in chunks:\n",
    "    completion = openai.ChatCompletion.create(\n",
    "    model=\"gpt-3.5-turbo\",\n",
    "    messages=[\n",
    "            {\"role\": \"system\", \"content\": \"You are a helpful assistant that extracts validated clinical questionnaires and puts them into a list.\"},\n",
    "            {\"role\": \"user\", \"content\": chunk},\n",
    "        ]\n",
    "    )\n",
    "    answer = completion[\"choices\"][0][\"message\"][\"content\"]\n",
    "    answers.append(answer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "# answers = ['\\n\\n- Patient Global Impression of Severity (PGI-S)\\n- Patient Global Impression of Change (PGI-C)\\n- Symptoms of aCKD questionnaire (SCKDQ)\\n- Short Form 36 (SF-36)\\n- EuroQol 5 Dimension 5 Level Health Utility Index (EQ-5D-5L)\\n- EuroQol Visual Analogue Scale (EQ-VAS)\\n- Work Productivity and Activity Impairment Questionnaire (WPAI-ANS-CPV)\\n- Healthcare resource utilization (participants-reported)\\n- Actigraphy (wearable)',\n",
    "#  '\\n\\n- Patient Benefit Index, (PBI)\\n- European Quality of Life 5-Dimension Questionnaire, (EQ-5D)\\n- Chronic Kidney Disease - Anemia Questionnaire (CKD-AQ)\\n- Patient Global Impression of Severity (PGI-S)\\n- Patient Global Impression of Change (PGI-C)\\n- SF-36\\n- EQ-5D-5L\\n- EQ-VAS\\n- Work Productivity and Activity Impairment - Anemia Specific (WPAI-ANS-CPV)',\n",
    "#  '\\n\\n- Patient Benefit Index, (PBI)\\n- European Quality of Life 5-Dimension Questionnaire, (EQ-5D)',\n",
    "#  'No validated clinical questionnaires were used in this text.',\n",
    "#  'No validated clinical questionnaires were used in this text.',\n",
    "#  '\\n\\n- Patient Benefit Index, (PBI)\\n- European Quality of Life 5-Dimension Questionnaire, (EQ-5D)',\n",
    "#  '\\n\\n- Chronic Kidney Disease - Anemia Questionnaire (CKD-AQ)\\n- Patient Global Impression of Severity (PGI-S) and Patient Global Impression of Change (PGI-C)\\n- Health Related Quality of Life (SF-36)\\n- Health Status (EQ-5D-5L & EQ-VAS)\\n- Work Productivity and Activity Impairment (WPAI-ANS-CPV)',\n",
    "#  '\\n\\n- Patient Benefit Index, (PBI)\\n- European Quality of Life 5-Dimension Questionnaire, (EQ-5D)\\n- Chronic Kidney Disease - Anemia Questionnaire, (CKD-AQ)\\n- EuroQol 5 Dimension 5 Level Health Utility Index, (EQ-5D-5L)\\n- EuroQol Visual Analogue Scale, (EQ-VAS)',\n",
    "#  '\\n\\n- Work Productivity and Activity Impairment Questionnaire: Anemic Symptoms Clinical Practice Version, (WPAI-ANS-CPV)\\n- Short Form -36, (SF-36)\\n- Patient Global Impression of Change, (PGI-C)\\n- Patient Global Impression of Severity, (PGI-S)',\n",
    "#  '\\n\\n- Patient Benefit Index (PBI)\\n- European Quality of Life 5-Dimension Questionnaire (EQ-5D)',\n",
    "#  '\\n\\n- Patient Benefit Index (PBI)\\n- European Quality of Life 5-Dimension Questionnaire (EQ-5D)']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[\"- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)\\n- Australian Code for the Responsible Conduct of Research, 2018 (the Code)\\n- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)\\n- MSQOL-54, validated tool designed to measure HRQOL in people with MS\\n['PROTOCOL', 'An Online Educational Course for People with MS: A randomised', 'controlled trial of course effectiveness', 'Protocol Number: #1', 'Version: #3', 'Date: 13/12/2021', 'Author/s:', 'Dr Sandra Neate', 'Dr Jeanette Reece', 'Mr Will Bevens', 'Ms Maggie Yu', 'Dr Steve Simpson-Yap', 'Sponsor/s:', 'None', 'CONFIDENTIAL', 'This document is confidential and the property of The University of Melbourne. No part of it may', 'be transmitted, reproduced, published, or used without prior written authorization from the', 'institution.', 'Statement of Compliance', 'This study will be conducted in compliance with all stipulation of this protocol, the conditions of', 'the ethics committee approval, the NHMRC National Statement on ethical Conduct in Human', 'Research (2007 updated 2018). Australian Code for the Responsible Conduct of', 'Research, 2018 (the Code) and the principles of the Note for Guidance on Good Clinical', 'Practice (CPMP/ICH-135/95).']\\n- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)\\n- Australian Code for the Responsible Conduct of Research, 2018 (the Code)\\n- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)\",\n",
       " '- MSQOL-54, Multiple Sclerosis Quality of Life-54 instrument \\n- IPAQ-SF, International Physical Activity Questionnaire - Short Form\\n- FSS, Fatigue Severity Scale \\n- MAQ, Mindfulness Adherence Questionnaire \\n- PDDS, Patient-Determined Disease Steps \\n- PHC, Physical Health Composite\\n- MHC, Mental Health Composite\\n- MSPSS, Multidimensional Scale of Perceived Social Support \\n- UWSE, University of Washington Self-Efficacy',\n",
       " '- Diet Habits Questionnaire\\n- NEU Multiple Sclerosis Online Course (MSOC) \\n- Dermatology Life Quality Index (DLQI)\\n- European Quality of Life 5-Dimension Questionnaire (EQ-5D)',\n",
       " '- IPAQ-SF, The International Physical Activity Questionnaire - Short Form\\n- DHQ, Diet Habits Questionnaire\\nStudy Name: An Online Educational Course for People with MS: A randomised controlled trial of course effectiveness\\nProtocol Number: 1\\nVersion & date: Version 3, dated 13 December 2021',\n",
       " '- SCQ, Self-administered Comorbidity Questionnaire\\n- MSPSS, Multidimensional Scale of Perceived Social Support\\n- MSQOL-54, Multiple Sclerosis Quality of Life-54\\n- FSS, Fatigue Severity Scale\\n- HADS, Hospital Anxiety and Depression Scale\\n- PDDS, Patient-Determined Disease Steps\\n- UWSE survey, University of Washington Self-Efficacy survey',\n",
       " '- MSQOL-54, Multiple Sclerosis Quality of Life 54\\n- PHC, Physical Health Composite\\n- MHC, Mental Health Composite\\n- EQ-5D, European Quality of Life 5-Dimension Questionnaire\\n- DLQI, Dermatology Life Quality Index',\n",
       " 'There are no validated clinical questionnaires mentioned in the text. The text describes a randomized controlled trial of an online educational course for people with MS, which includes an integrated lifestyle modification program with seven modules. The study will use qualitative interviewing to assess the effectiveness of the course. The text does not mention any specific questionnaires used in the trial.',\n",
       " '- IPAQ-SF, International Physical Activity Questionnaire Short Form\\n- MAQ, Meditation Assessment Questionnaire\\n- DHQ, Diet History Questionnaire\\n- EQ-5D, European Quality of Life 5-Dimension Questionnaire\\n- DLQI, Dermatology Life Quality Index',\n",
       " '- MSQOL-54, Health-related quality of life: MS Quality of Life 54 questionnaire\\n- PDDS, Patient-determined disease steps\\n- HADS, Hospital Anxiety and Depression Scale\\n- FSS, Fatigue Severity Scale\\n- UWSE-6, Generalized Self-Efficacy Scale\\n- No other validated clinical questionnaires were found in the text.',\n",
       " '- MSQOL-54, Multiple Sclerosis Quality of Life 54-item survey\\n- FSS, Fatigue Severity Scale\\n- HADS, Hospital Anxiety and Depression Scale\\n- UWSE, University of Washington Self-Efficacy Scale',\n",
       " 'There are no validated clinical questionnaires mentioned in this text.',\n",
       " '- DLQI, Dermatology Life Quality Index\\n- EQ-5D, European Quality of Life 5-Dimension Questionnaire',\n",
       " '- DHQ, Dietary Habits Questionnaire\\n- HADS, Hospital Anxiety and Depression\\n- UWSE-6, University of Washington Self-Efficacy Scale\\n- MSPSS, Multidimensional Scale of Perceived Social Support\\n- MSQOL54.pdt, Multiple Sclerosis Quality of Life-54\\n- FSS, Fatigue Severity Scale Questionnaire\\n- Neuro-QoL, Quality of Life in Neurological Disorders\\n- IPAQ, International Physical Activity Questionnaire\\n- PARADISE-24, Psychological And Reactivation and Distress In MS - 24 questionnaire',\n",
       " '- DLQI, Dermatology Life Quality Index\\n- EQ-5D, European Quality of Life 5-Dimension Questionnaire\\n- FCBP, Females of childbearing potential\\n- FDA, Food and Drug Administration\\n- Fatigue Severity Scale\\n- Mindfulness Adherence Questionnaire',\n",
       " '- NARCOMS registry: fatigue assessment\\n- DLQI, Dermatology Life Quality Index\\n- MS Invigor8\\n- EQ-5D, European Quality of Life 5-Dimension Questionnaire\\n- Diet Habits Questionnaire\\n- Self-Administered Comorbidity Questionnaire\\n- Stress Management for MS\\n- Mindfulness-Based Stress Reduction\\n- Vitamin D Supplements Use\\n- Behavioral Nutrition Interventions\\n- Body Mass Index\\n- Interpreting the significance of changes in health-related quality-of-life scores\\n- Impact of mindful-based stress reduction for people with multiple sclerosis\\n- Higher quality diet and non-consumption of meat\\n- Australian standard classification of cultural and ethnic groups\\n- Self-administered comorbidity questionnaire\\n- The perceived benefits and barriers to exercise participation\\n- Health-related quality of life and symptom research in glioblastoma multiforme patients\\n- Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis\\n- Stress management interventions for multiple sclerosis',\n",
       " '- DLQI, Dermatology Life Quality Index\\n- EQ-5D, European Quality of Life 5-Dimension Questionnaire\\n- FCBP, Females of childbearing potential\\n- FDA, Food and Drug Administration']"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "answers"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)\n",
      "- Australian Code for the Responsible Conduct of Research, 2018 (the Code)\n",
      "- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)\n",
      "- MSQOL-54, validated tool designed to measure HRQOL in people with MS\n",
      "['PROTOCOL', 'An Online Educational Course for People with MS: A randomised', 'controlled trial of course effectiveness', 'Protocol Number: #1', 'Version: #3', 'Date: 13/12/2021', 'Author/s:', 'Dr Sandra Neate', 'Dr Jeanette Reece', 'Mr Will Bevens', 'Ms Maggie Yu', 'Dr Steve Simpson-Yap', 'Sponsor/s:', 'None', 'CONFIDENTIAL', 'This document is confidential and the property of The University of Melbourne. No part of it may', 'be transmitted, reproduced, published, or used without prior written authorization from the', 'institution.', 'Statement of Compliance', 'This study will be conducted in compliance with all stipulation of this protocol, the conditions of', 'the ethics committee approval, the NHMRC National Statement on ethical Conduct in Human', 'Research (2007 updated 2018). Australian Code for the Responsible Conduct of', 'Research, 2018 (the Code) and the principles of the Note for Guidance on Good Clinical', 'Practice (CPMP/ICH-135/95).']\n",
      "- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)\n",
      "- Australian Code for the Responsible Conduct of Research, 2018 (the Code)\n",
      "- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life-54 instrument \n",
      "- IPAQ-SF, International Physical Activity Questionnaire - Short Form\n",
      "- FSS, Fatigue Severity Scale \n",
      "- MAQ, Mindfulness Adherence Questionnaire \n",
      "- PDDS, Patient-Determined Disease Steps \n",
      "- PHC, Physical Health Composite\n",
      "- MHC, Mental Health Composite\n",
      "- MSPSS, Multidimensional Scale of Perceived Social Support \n",
      "- UWSE, University of Washington Self-Efficacy\n",
      "- Diet Habits Questionnaire\n",
      "- NEU Multiple Sclerosis Online Course (MSOC) \n",
      "- Dermatology Life Quality Index (DLQI)\n",
      "- European Quality of Life 5-Dimension Questionnaire (EQ-5D)\n",
      "- IPAQ-SF, The International Physical Activity Questionnaire - Short Form\n",
      "- DHQ, Diet Habits Questionnaire\n",
      "Study Name: An Online Educational Course for People with MS: A randomised controlled trial of course effectiveness\n",
      "Protocol Number: 1\n",
      "Version & date: Version 3, dated 13 December 2021\n",
      "- SCQ, Self-administered Comorbidity Questionnaire\n",
      "- MSPSS, Multidimensional Scale of Perceived Social Support\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life-54\n",
      "- FSS, Fatigue Severity Scale\n",
      "- HADS, Hospital Anxiety and Depression Scale\n",
      "- PDDS, Patient-Determined Disease Steps\n",
      "- UWSE survey, University of Washington Self-Efficacy survey\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life 54\n",
      "- PHC, Physical Health Composite\n",
      "- MHC, Mental Health Composite\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "There are no validated clinical questionnaires mentioned in the text. The text describes a randomized controlled trial of an online educational course for people with MS, which includes an integrated lifestyle modification program with seven modules. The study will use qualitative interviewing to assess the effectiveness of the course. The text does not mention any specific questionnaires used in the trial.\n",
      "- IPAQ-SF, International Physical Activity Questionnaire Short Form\n",
      "- MAQ, Meditation Assessment Questionnaire\n",
      "- DHQ, Diet History Questionnaire\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- MSQOL-54, Health-related quality of life: MS Quality of Life 54 questionnaire\n",
      "- PDDS, Patient-determined disease steps\n",
      "- HADS, Hospital Anxiety and Depression Scale\n",
      "- FSS, Fatigue Severity Scale\n",
      "- UWSE-6, Generalized Self-Efficacy Scale\n",
      "- No other validated clinical questionnaires were found in the text.\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life 54-item survey\n",
      "- FSS, Fatigue Severity Scale\n",
      "- HADS, Hospital Anxiety and Depression Scale\n",
      "- UWSE, University of Washington Self-Efficacy Scale\n",
      "There are no validated clinical questionnaires mentioned in this text.\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- DHQ, Dietary Habits Questionnaire\n",
      "- HADS, Hospital Anxiety and Depression\n",
      "- UWSE-6, University of Washington Self-Efficacy Scale\n",
      "- MSPSS, Multidimensional Scale of Perceived Social Support\n",
      "- MSQOL54.pdt, Multiple Sclerosis Quality of Life-54\n",
      "- FSS, Fatigue Severity Scale Questionnaire\n",
      "- Neuro-QoL, Quality of Life in Neurological Disorders\n",
      "- IPAQ, International Physical Activity Questionnaire\n",
      "- PARADISE-24, Psychological And Reactivation and Distress In MS - 24 questionnaire\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- FCBP, Females of childbearing potential\n",
      "- FDA, Food and Drug Administration\n",
      "- Fatigue Severity Scale\n",
      "- Mindfulness Adherence Questionnaire\n",
      "- NARCOMS registry: fatigue assessment\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- MS Invigor8\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- Diet Habits Questionnaire\n",
      "- Self-Administered Comorbidity Questionnaire\n",
      "- Stress Management for MS\n",
      "- Mindfulness-Based Stress Reduction\n",
      "- Vitamin D Supplements Use\n",
      "- Behavioral Nutrition Interventions\n",
      "- Body Mass Index\n",
      "- Interpreting the significance of changes in health-related quality-of-life scores\n",
      "- Impact of mindful-based stress reduction for people with multiple sclerosis\n",
      "- Higher quality diet and non-consumption of meat\n",
      "- Australian standard classification of cultural and ethnic groups\n",
      "- Self-administered comorbidity questionnaire\n",
      "- The perceived benefits and barriers to exercise participation\n",
      "- Health-related quality of life and symptom research in glioblastoma multiforme patients\n",
      "- Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis\n",
      "- Stress management interventions for multiple sclerosis\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- FCBP, Females of childbearing potential\n",
      "- FDA, Food and Drug Administration\n"
     ]
    }
   ],
   "source": [
    "for answer in answers:\n",
    "    print(answer)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Answers\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)\n",
      "- Australian Code for the Responsible Conduct of Research, 2018 (the Code)\n",
      "- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)\n",
      "- MSQOL-54, validated tool designed to measure HRQOL in people with MS\n",
      "['PROTOCOL', 'An Online Educational Course for People with MS: A randomised', 'controlled trial of course effectiveness', 'Protocol Number: #1', 'Version: #3', 'Date: 13/12/2021', 'Author/s:', 'Dr Sandra Neate', 'Dr Jeanette Reece', 'Mr Will Bevens', 'Ms Maggie Yu', 'Dr Steve Simpson-Yap', 'Sponsor/s:', 'None', 'CONFIDENTIAL', 'This document is confidential and the property of The University of Melbourne. No part of it may', 'be transmitted, reproduced, published, or used without prior written authorization from the', 'institution.', 'Statement of Compliance', 'This study will be conducted in compliance with all stipulation of this protocol, the conditions of', 'the ethics committee approval, the NHMRC National Statement on ethical Conduct in Human', 'Research (2007 updated 2018). Australian Code for the Responsible Conduct of', 'Research, 2018 (the Code) and the principles of the Note for Guidance on Good Clinical', 'Practice (CPMP/ICH-135/95).']\n",
      "- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)\n",
      "- Australian Code for the Responsible Conduct of Research, 2018 (the Code)\n",
      "- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life-54 instrument \n",
      "- IPAQ-SF, International Physical Activity Questionnaire - Short Form\n",
      "- FSS, Fatigue Severity Scale \n",
      "- MAQ, Mindfulness Adherence Questionnaire \n",
      "- PDDS, Patient-Determined Disease Steps \n",
      "- PHC, Physical Health Composite\n",
      "- MHC, Mental Health Composite\n",
      "- MSPSS, Multidimensional Scale of Perceived Social Support \n",
      "- UWSE, University of Washington Self-Efficacy\n",
      "- Diet Habits Questionnaire\n",
      "- NEU Multiple Sclerosis Online Course (MSOC) \n",
      "- Dermatology Life Quality Index (DLQI)\n",
      "- European Quality of Life 5-Dimension Questionnaire (EQ-5D)\n",
      "- IPAQ-SF, The International Physical Activity Questionnaire - Short Form\n",
      "- DHQ, Diet Habits Questionnaire\n",
      "Study Name: An Online Educational Course for People with MS: A randomised controlled trial of course effectiveness\n",
      "Protocol Number: 1\n",
      "Version & date: Version 3, dated 13 December 2021\n",
      "- SCQ, Self-administered Comorbidity Questionnaire\n",
      "- MSPSS, Multidimensional Scale of Perceived Social Support\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life-54\n",
      "- FSS, Fatigue Severity Scale\n",
      "- HADS, Hospital Anxiety and Depression Scale\n",
      "- PDDS, Patient-Determined Disease Steps\n",
      "- UWSE survey, University of Washington Self-Efficacy survey\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life 54\n",
      "- PHC, Physical Health Composite\n",
      "- MHC, Mental Health Composite\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "There are no validated clinical questionnaires mentioned in the text. The text describes a randomized controlled trial of an online educational course for people with MS, which includes an integrated lifestyle modification program with seven modules. The study will use qualitative interviewing to assess the effectiveness of the course. The text does not mention any specific questionnaires used in the trial.\n",
      "- IPAQ-SF, International Physical Activity Questionnaire Short Form\n",
      "- MAQ, Meditation Assessment Questionnaire\n",
      "- DHQ, Diet History Questionnaire\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- MSQOL-54, Health-related quality of life: MS Quality of Life 54 questionnaire\n",
      "- PDDS, Patient-determined disease steps\n",
      "- HADS, Hospital Anxiety and Depression Scale\n",
      "- FSS, Fatigue Severity Scale\n",
      "- UWSE-6, Generalized Self-Efficacy Scale\n",
      "- No other validated clinical questionnaires were found in the text.\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life 54-item survey\n",
      "- FSS, Fatigue Severity Scale\n",
      "- HADS, Hospital Anxiety and Depression Scale\n",
      "- UWSE, University of Washington Self-Efficacy Scale\n",
      "There are no validated clinical questionnaires mentioned in this text.\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- DHQ, Dietary Habits Questionnaire\n",
      "- HADS, Hospital Anxiety and Depression\n",
      "- UWSE-6, University of Washington Self-Efficacy Scale\n",
      "- MSPSS, Multidimensional Scale of Perceived Social Support\n",
      "- MSQOL54.pdt, Multiple Sclerosis Quality of Life-54\n",
      "- FSS, Fatigue Severity Scale Questionnaire\n",
      "- Neuro-QoL, Quality of Life in Neurological Disorders\n",
      "- IPAQ, International Physical Activity Questionnaire\n",
      "- PARADISE-24, Psychological And Reactivation and Distress In MS - 24 questionnaire\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- FCBP, Females of childbearing potential\n",
      "- FDA, Food and Drug Administration\n",
      "- Fatigue Severity Scale\n",
      "- Mindfulness Adherence Questionnaire\n",
      "- NARCOMS registry: fatigue assessment\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- MS Invigor8\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- Diet Habits Questionnaire\n",
      "- Self-Administered Comorbidity Questionnaire\n",
      "- Stress Management for MS\n",
      "- Mindfulness-Based Stress Reduction\n",
      "- Vitamin D Supplements Use\n",
      "- Behavioral Nutrition Interventions\n",
      "- Body Mass Index\n",
      "- Interpreting the significance of changes in health-related quality-of-life scores\n",
      "- Impact of mindful-based stress reduction for people with multiple sclerosis\n",
      "- Higher quality diet and non-consumption of meat\n",
      "- Australian standard classification of cultural and ethnic groups\n",
      "- Self-administered comorbidity questionnaire\n",
      "- The perceived benefits and barriers to exercise participation\n",
      "- Health-related quality of life and symptom research in glioblastoma multiforme patients\n",
      "- Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis\n",
      "- Stress management interventions for multiple sclerosis\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- FCBP, Females of childbearing potential\n",
      "- FDA, Food and Drug Administration\n"
     ]
    }
   ],
   "source": [
    "for answer in answers:\n",
    "    print(answer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "all_answers = []\n",
    "for answer in answers:\n",
    "    all_answers.append(answer.split(\"\\n\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)',\n",
       "  '- Australian Code for the Responsible Conduct of Research, 2018 (the Code)',\n",
       "  '- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)',\n",
       "  '- MSQOL-54, validated tool designed to measure HRQOL in people with MS',\n",
       "  \"['PROTOCOL', 'An Online Educational Course for People with MS: A randomised', 'controlled trial of course effectiveness', 'Protocol Number: #1', 'Version: #3', 'Date: 13/12/2021', 'Author/s:', 'Dr Sandra Neate', 'Dr Jeanette Reece', 'Mr Will Bevens', 'Ms Maggie Yu', 'Dr Steve Simpson-Yap', 'Sponsor/s:', 'None', 'CONFIDENTIAL', 'This document is confidential and the property of The University of Melbourne. No part of it may', 'be transmitted, reproduced, published, or used without prior written authorization from the', 'institution.', 'Statement of Compliance', 'This study will be conducted in compliance with all stipulation of this protocol, the conditions of', 'the ethics committee approval, the NHMRC National Statement on ethical Conduct in Human', 'Research (2007 updated 2018). Australian Code for the Responsible Conduct of', 'Research, 2018 (the Code) and the principles of the Note for Guidance on Good Clinical', 'Practice (CPMP/ICH-135/95).']\",\n",
       "  '- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)',\n",
       "  '- Australian Code for the Responsible Conduct of Research, 2018 (the Code)',\n",
       "  '- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)'],\n",
       " ['- MSQOL-54, Multiple Sclerosis Quality of Life-54 instrument ',\n",
       "  '- IPAQ-SF, International Physical Activity Questionnaire - Short Form',\n",
       "  '- FSS, Fatigue Severity Scale ',\n",
       "  '- MAQ, Mindfulness Adherence Questionnaire ',\n",
       "  '- PDDS, Patient-Determined Disease Steps ',\n",
       "  '- PHC, Physical Health Composite',\n",
       "  '- MHC, Mental Health Composite',\n",
       "  '- MSPSS, Multidimensional Scale of Perceived Social Support ',\n",
       "  '- UWSE, University of Washington Self-Efficacy'],\n",
       " ['- Diet Habits Questionnaire',\n",
       "  '- NEU Multiple Sclerosis Online Course (MSOC) ',\n",
       "  '- Dermatology Life Quality Index (DLQI)',\n",
       "  '- European Quality of Life 5-Dimension Questionnaire (EQ-5D)'],\n",
       " ['- IPAQ-SF, The International Physical Activity Questionnaire - Short Form',\n",
       "  '- DHQ, Diet Habits Questionnaire',\n",
       "  'Study Name: An Online Educational Course for People with MS: A randomised controlled trial of course effectiveness',\n",
       "  'Protocol Number: 1',\n",
       "  'Version & date: Version 3, dated 13 December 2021'],\n",
       " ['- SCQ, Self-administered Comorbidity Questionnaire',\n",
       "  '- MSPSS, Multidimensional Scale of Perceived Social Support',\n",
       "  '- MSQOL-54, Multiple Sclerosis Quality of Life-54',\n",
       "  '- FSS, Fatigue Severity Scale',\n",
       "  '- HADS, Hospital Anxiety and Depression Scale',\n",
       "  '- PDDS, Patient-Determined Disease Steps',\n",
       "  '- UWSE survey, University of Washington Self-Efficacy survey'],\n",
       " ['- MSQOL-54, Multiple Sclerosis Quality of Life 54',\n",
       "  '- PHC, Physical Health Composite',\n",
       "  '- MHC, Mental Health Composite',\n",
       "  '- EQ-5D, European Quality of Life 5-Dimension Questionnaire',\n",
       "  '- DLQI, Dermatology Life Quality Index'],\n",
       " ['There are no validated clinical questionnaires mentioned in the text. The text describes a randomized controlled trial of an online educational course for people with MS, which includes an integrated lifestyle modification program with seven modules. The study will use qualitative interviewing to assess the effectiveness of the course. The text does not mention any specific questionnaires used in the trial.'],\n",
       " ['- IPAQ-SF, International Physical Activity Questionnaire Short Form',\n",
       "  '- MAQ, Meditation Assessment Questionnaire',\n",
       "  '- DHQ, Diet History Questionnaire',\n",
       "  '- EQ-5D, European Quality of Life 5-Dimension Questionnaire',\n",
       "  '- DLQI, Dermatology Life Quality Index'],\n",
       " ['- MSQOL-54, Health-related quality of life: MS Quality of Life 54 questionnaire',\n",
       "  '- PDDS, Patient-determined disease steps',\n",
       "  '- HADS, Hospital Anxiety and Depression Scale',\n",
       "  '- FSS, Fatigue Severity Scale',\n",
       "  '- UWSE-6, Generalized Self-Efficacy Scale',\n",
       "  '- No other validated clinical questionnaires were found in the text.'],\n",
       " ['- MSQOL-54, Multiple Sclerosis Quality of Life 54-item survey',\n",
       "  '- FSS, Fatigue Severity Scale',\n",
       "  '- HADS, Hospital Anxiety and Depression Scale',\n",
       "  '- UWSE, University of Washington Self-Efficacy Scale'],\n",
       " ['There are no validated clinical questionnaires mentioned in this text.'],\n",
       " ['- DLQI, Dermatology Life Quality Index',\n",
       "  '- EQ-5D, European Quality of Life 5-Dimension Questionnaire'],\n",
       " ['- DHQ, Dietary Habits Questionnaire',\n",
       "  '- HADS, Hospital Anxiety and Depression',\n",
       "  '- UWSE-6, University of Washington Self-Efficacy Scale',\n",
       "  '- MSPSS, Multidimensional Scale of Perceived Social Support',\n",
       "  '- MSQOL54.pdt, Multiple Sclerosis Quality of Life-54',\n",
       "  '- FSS, Fatigue Severity Scale Questionnaire',\n",
       "  '- Neuro-QoL, Quality of Life in Neurological Disorders',\n",
       "  '- IPAQ, International Physical Activity Questionnaire',\n",
       "  '- PARADISE-24, Psychological And Reactivation and Distress In MS - 24 questionnaire'],\n",
       " ['- DLQI, Dermatology Life Quality Index',\n",
       "  '- EQ-5D, European Quality of Life 5-Dimension Questionnaire',\n",
       "  '- FCBP, Females of childbearing potential',\n",
       "  '- FDA, Food and Drug Administration',\n",
       "  '- Fatigue Severity Scale',\n",
       "  '- Mindfulness Adherence Questionnaire'],\n",
       " ['- NARCOMS registry: fatigue assessment',\n",
       "  '- DLQI, Dermatology Life Quality Index',\n",
       "  '- MS Invigor8',\n",
       "  '- EQ-5D, European Quality of Life 5-Dimension Questionnaire',\n",
       "  '- Diet Habits Questionnaire',\n",
       "  '- Self-Administered Comorbidity Questionnaire',\n",
       "  '- Stress Management for MS',\n",
       "  '- Mindfulness-Based Stress Reduction',\n",
       "  '- Vitamin D Supplements Use',\n",
       "  '- Behavioral Nutrition Interventions',\n",
       "  '- Body Mass Index',\n",
       "  '- Interpreting the significance of changes in health-related quality-of-life scores',\n",
       "  '- Impact of mindful-based stress reduction for people with multiple sclerosis',\n",
       "  '- Higher quality diet and non-consumption of meat',\n",
       "  '- Australian standard classification of cultural and ethnic groups',\n",
       "  '- Self-administered comorbidity questionnaire',\n",
       "  '- The perceived benefits and barriers to exercise participation',\n",
       "  '- Health-related quality of life and symptom research in glioblastoma multiforme patients',\n",
       "  '- Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis',\n",
       "  '- Stress management interventions for multiple sclerosis'],\n",
       " ['- DLQI, Dermatology Life Quality Index',\n",
       "  '- EQ-5D, European Quality of Life 5-Dimension Questionnaire',\n",
       "  '- FCBP, Females of childbearing potential',\n",
       "  '- FDA, Food and Drug Administration']]"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_answers"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)\n",
      "- Australian Code for the Responsible Conduct of Research, 2018 (the Code)\n",
      "- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)\n",
      "- MSQOL-54, validated tool designed to measure HRQOL in people with MS\n",
      "['PROTOCOL', 'An Online Educational Course for People with MS: A randomised', 'controlled trial of course effectiveness', 'Protocol Number: #1', 'Version: #3', 'Date: 13/12/2021', 'Author/s:', 'Dr Sandra Neate', 'Dr Jeanette Reece', 'Mr Will Bevens', 'Ms Maggie Yu', 'Dr Steve Simpson-Yap', 'Sponsor/s:', 'None', 'CONFIDENTIAL', 'This document is confidential and the property of The University of Melbourne. No part of it may', 'be transmitted, reproduced, published, or used without prior written authorization from the', 'institution.', 'Statement of Compliance', 'This study will be conducted in compliance with all stipulation of this protocol, the conditions of', 'the ethics committee approval, the NHMRC National Statement on ethical Conduct in Human', 'Research (2007 updated 2018). Australian Code for the Responsible Conduct of', 'Research, 2018 (the Code) and the principles of the Note for Guidance on Good Clinical', 'Practice (CPMP/ICH-135/95).']\n",
      "- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)\n",
      "- Australian Code for the Responsible Conduct of Research, 2018 (the Code)\n",
      "- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life-54 instrument \n",
      "- IPAQ-SF, International Physical Activity Questionnaire - Short Form\n",
      "- FSS, Fatigue Severity Scale \n",
      "- MAQ, Mindfulness Adherence Questionnaire \n",
      "- PDDS, Patient-Determined Disease Steps \n",
      "- PHC, Physical Health Composite\n",
      "- MHC, Mental Health Composite\n",
      "- MSPSS, Multidimensional Scale of Perceived Social Support \n",
      "- UWSE, University of Washington Self-Efficacy\n",
      "- Diet Habits Questionnaire\n",
      "- NEU Multiple Sclerosis Online Course (MSOC) \n",
      "- Dermatology Life Quality Index (DLQI)\n",
      "- European Quality of Life 5-Dimension Questionnaire (EQ-5D)\n",
      "- IPAQ-SF, The International Physical Activity Questionnaire - Short Form\n",
      "- DHQ, Diet Habits Questionnaire\n",
      "Study Name: An Online Educational Course for People with MS: A randomised controlled trial of course effectiveness\n",
      "Protocol Number: 1\n",
      "Version & date: Version 3, dated 13 December 2021\n",
      "- SCQ, Self-administered Comorbidity Questionnaire\n",
      "- MSPSS, Multidimensional Scale of Perceived Social Support\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life-54\n",
      "- FSS, Fatigue Severity Scale\n",
      "- HADS, Hospital Anxiety and Depression Scale\n",
      "- PDDS, Patient-Determined Disease Steps\n",
      "- UWSE survey, University of Washington Self-Efficacy survey\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life 54\n",
      "- PHC, Physical Health Composite\n",
      "- MHC, Mental Health Composite\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "There are no validated clinical questionnaires mentioned in the text. The text describes a randomized controlled trial of an online educational course for people with MS, which includes an integrated lifestyle modification program with seven modules. The study will use qualitative interviewing to assess the effectiveness of the course. The text does not mention any specific questionnaires used in the trial.\n",
      "- IPAQ-SF, International Physical Activity Questionnaire Short Form\n",
      "- MAQ, Meditation Assessment Questionnaire\n",
      "- DHQ, Diet History Questionnaire\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- MSQOL-54, Health-related quality of life: MS Quality of Life 54 questionnaire\n",
      "- PDDS, Patient-determined disease steps\n",
      "- HADS, Hospital Anxiety and Depression Scale\n",
      "- FSS, Fatigue Severity Scale\n",
      "- UWSE-6, Generalized Self-Efficacy Scale\n",
      "- No other validated clinical questionnaires were found in the text.\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life 54-item survey\n",
      "- FSS, Fatigue Severity Scale\n",
      "- HADS, Hospital Anxiety and Depression Scale\n",
      "- UWSE, University of Washington Self-Efficacy Scale\n",
      "There are no validated clinical questionnaires mentioned in this text.\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- DHQ, Dietary Habits Questionnaire\n",
      "- HADS, Hospital Anxiety and Depression\n",
      "- UWSE-6, University of Washington Self-Efficacy Scale\n",
      "- MSPSS, Multidimensional Scale of Perceived Social Support\n",
      "- MSQOL54.pdt, Multiple Sclerosis Quality of Life-54\n",
      "- FSS, Fatigue Severity Scale Questionnaire\n",
      "- Neuro-QoL, Quality of Life in Neurological Disorders\n",
      "- IPAQ, International Physical Activity Questionnaire\n",
      "- PARADISE-24, Psychological And Reactivation and Distress In MS - 24 questionnaire\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- FCBP, Females of childbearing potential\n",
      "- FDA, Food and Drug Administration\n",
      "- Fatigue Severity Scale\n",
      "- Mindfulness Adherence Questionnaire\n",
      "- NARCOMS registry: fatigue assessment\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- MS Invigor8\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- Diet Habits Questionnaire\n",
      "- Self-Administered Comorbidity Questionnaire\n",
      "- Stress Management for MS\n",
      "- Mindfulness-Based Stress Reduction\n",
      "- Vitamin D Supplements Use\n",
      "- Behavioral Nutrition Interventions\n",
      "- Body Mass Index\n",
      "- Interpreting the significance of changes in health-related quality-of-life scores\n",
      "- Impact of mindful-based stress reduction for people with multiple sclerosis\n",
      "- Higher quality diet and non-consumption of meat\n",
      "- Australian standard classification of cultural and ethnic groups\n",
      "- Self-administered comorbidity questionnaire\n",
      "- The perceived benefits and barriers to exercise participation\n",
      "- Health-related quality of life and symptom research in glioblastoma multiforme patients\n",
      "- Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis\n",
      "- Stress management interventions for multiple sclerosis\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- FCBP, Females of childbearing potential\n",
      "- FDA, Food and Drug Administration\n"
     ]
    }
   ],
   "source": [
    "my_answers = []\n",
    "for lists in all_answers:\n",
    "    # print(lists)\n",
    "    for point in lists:\n",
    "        print(point)\n",
    "        if point not in my_answers:\n",
    "            my_answers.append(point)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)',\n",
       " '- Australian Code for the Responsible Conduct of Research, 2018 (the Code)',\n",
       " '- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)',\n",
       " '- MSQOL-54, validated tool designed to measure HRQOL in people with MS',\n",
       " \"['PROTOCOL', 'An Online Educational Course for People with MS: A randomised', 'controlled trial of course effectiveness', 'Protocol Number: #1', 'Version: #3', 'Date: 13/12/2021', 'Author/s:', 'Dr Sandra Neate', 'Dr Jeanette Reece', 'Mr Will Bevens', 'Ms Maggie Yu', 'Dr Steve Simpson-Yap', 'Sponsor/s:', 'None', 'CONFIDENTIAL', 'This document is confidential and the property of The University of Melbourne. No part of it may', 'be transmitted, reproduced, published, or used without prior written authorization from the', 'institution.', 'Statement of Compliance', 'This study will be conducted in compliance with all stipulation of this protocol, the conditions of', 'the ethics committee approval, the NHMRC National Statement on ethical Conduct in Human', 'Research (2007 updated 2018). Australian Code for the Responsible Conduct of', 'Research, 2018 (the Code) and the principles of the Note for Guidance on Good Clinical', 'Practice (CPMP/ICH-135/95).']\",\n",
       " '- MSQOL-54, Multiple Sclerosis Quality of Life-54 instrument ',\n",
       " '- IPAQ-SF, International Physical Activity Questionnaire - Short Form',\n",
       " '- FSS, Fatigue Severity Scale ',\n",
       " '- MAQ, Mindfulness Adherence Questionnaire ',\n",
       " '- PDDS, Patient-Determined Disease Steps ',\n",
       " '- PHC, Physical Health Composite',\n",
       " '- MHC, Mental Health Composite',\n",
       " '- MSPSS, Multidimensional Scale of Perceived Social Support ',\n",
       " '- UWSE, University of Washington Self-Efficacy',\n",
       " '- Diet Habits Questionnaire',\n",
       " '- NEU Multiple Sclerosis Online Course (MSOC) ',\n",
       " '- Dermatology Life Quality Index (DLQI)',\n",
       " '- European Quality of Life 5-Dimension Questionnaire (EQ-5D)',\n",
       " '- IPAQ-SF, The International Physical Activity Questionnaire - Short Form',\n",
       " '- DHQ, Diet Habits Questionnaire',\n",
       " 'Study Name: An Online Educational Course for People with MS: A randomised controlled trial of course effectiveness',\n",
       " 'Protocol Number: 1',\n",
       " 'Version & date: Version 3, dated 13 December 2021',\n",
       " '- SCQ, Self-administered Comorbidity Questionnaire',\n",
       " '- MSPSS, Multidimensional Scale of Perceived Social Support',\n",
       " '- MSQOL-54, Multiple Sclerosis Quality of Life-54',\n",
       " '- FSS, Fatigue Severity Scale',\n",
       " '- HADS, Hospital Anxiety and Depression Scale',\n",
       " '- PDDS, Patient-Determined Disease Steps',\n",
       " '- UWSE survey, University of Washington Self-Efficacy survey',\n",
       " '- MSQOL-54, Multiple Sclerosis Quality of Life 54',\n",
       " '- EQ-5D, European Quality of Life 5-Dimension Questionnaire',\n",
       " '- DLQI, Dermatology Life Quality Index',\n",
       " 'There are no validated clinical questionnaires mentioned in the text. The text describes a randomized controlled trial of an online educational course for people with MS, which includes an integrated lifestyle modification program with seven modules. The study will use qualitative interviewing to assess the effectiveness of the course. The text does not mention any specific questionnaires used in the trial.',\n",
       " '- IPAQ-SF, International Physical Activity Questionnaire Short Form',\n",
       " '- MAQ, Meditation Assessment Questionnaire',\n",
       " '- DHQ, Diet History Questionnaire',\n",
       " '- MSQOL-54, Health-related quality of life: MS Quality of Life 54 questionnaire',\n",
       " '- PDDS, Patient-determined disease steps',\n",
       " '- UWSE-6, Generalized Self-Efficacy Scale',\n",
       " '- No other validated clinical questionnaires were found in the text.',\n",
       " '- MSQOL-54, Multiple Sclerosis Quality of Life 54-item survey',\n",
       " '- UWSE, University of Washington Self-Efficacy Scale',\n",
       " 'There are no validated clinical questionnaires mentioned in this text.',\n",
       " '- DHQ, Dietary Habits Questionnaire',\n",
       " '- HADS, Hospital Anxiety and Depression',\n",
       " '- UWSE-6, University of Washington Self-Efficacy Scale',\n",
       " '- MSQOL54.pdt, Multiple Sclerosis Quality of Life-54',\n",
       " '- FSS, Fatigue Severity Scale Questionnaire',\n",
       " '- Neuro-QoL, Quality of Life in Neurological Disorders',\n",
       " '- IPAQ, International Physical Activity Questionnaire',\n",
       " '- PARADISE-24, Psychological And Reactivation and Distress In MS - 24 questionnaire',\n",
       " '- FCBP, Females of childbearing potential',\n",
       " '- FDA, Food and Drug Administration',\n",
       " '- Fatigue Severity Scale',\n",
       " '- Mindfulness Adherence Questionnaire',\n",
       " '- NARCOMS registry: fatigue assessment',\n",
       " '- MS Invigor8',\n",
       " '- Self-Administered Comorbidity Questionnaire',\n",
       " '- Stress Management for MS',\n",
       " '- Mindfulness-Based Stress Reduction',\n",
       " '- Vitamin D Supplements Use',\n",
       " '- Behavioral Nutrition Interventions',\n",
       " '- Body Mass Index',\n",
       " '- Interpreting the significance of changes in health-related quality-of-life scores',\n",
       " '- Impact of mindful-based stress reduction for people with multiple sclerosis',\n",
       " '- Higher quality diet and non-consumption of meat',\n",
       " '- Australian standard classification of cultural and ethnic groups',\n",
       " '- Self-administered comorbidity questionnaire',\n",
       " '- The perceived benefits and barriers to exercise participation',\n",
       " '- Health-related quality of life and symptom research in glioblastoma multiforme patients',\n",
       " '- Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis',\n",
       " '- Stress management interventions for multiple sclerosis']"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "my_answers"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)\n",
      "- Australian Code for the Responsible Conduct of Research, 2018 (the Code)\n",
      "- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)\n",
      "- MSQOL-54, validated tool designed to measure HRQOL in people with MS\n",
      "['PROTOCOL', 'An Online Educational Course for People with MS: A randomised', 'controlled trial of course effectiveness', 'Protocol Number: #1', 'Version: #3', 'Date: 13/12/2021', 'Author/s:', 'Dr Sandra Neate', 'Dr Jeanette Reece', 'Mr Will Bevens', 'Ms Maggie Yu', 'Dr Steve Simpson-Yap', 'Sponsor/s:', 'None', 'CONFIDENTIAL', 'This document is confidential and the property of The University of Melbourne. No part of it may', 'be transmitted, reproduced, published, or used without prior written authorization from the', 'institution.', 'Statement of Compliance', 'This study will be conducted in compliance with all stipulation of this protocol, the conditions of', 'the ethics committee approval, the NHMRC National Statement on ethical Conduct in Human', 'Research (2007 updated 2018). Australian Code for the Responsible Conduct of', 'Research, 2018 (the Code) and the principles of the Note for Guidance on Good Clinical', 'Practice (CPMP/ICH-135/95).']\n",
      "- NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)\n",
      "- Australian Code for the Responsible Conduct of Research, 2018 (the Code)\n",
      "- Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life-54 instrument \n",
      "- IPAQ-SF, International Physical Activity Questionnaire - Short Form\n",
      "- FSS, Fatigue Severity Scale \n",
      "- MAQ, Mindfulness Adherence Questionnaire \n",
      "- PDDS, Patient-Determined Disease Steps \n",
      "- PHC, Physical Health Composite\n",
      "- MHC, Mental Health Composite\n",
      "- MSPSS, Multidimensional Scale of Perceived Social Support \n",
      "- UWSE, University of Washington Self-Efficacy\n",
      "- Diet Habits Questionnaire\n",
      "- NEU Multiple Sclerosis Online Course (MSOC) \n",
      "- Dermatology Life Quality Index (DLQI)\n",
      "- European Quality of Life 5-Dimension Questionnaire (EQ-5D)\n",
      "- IPAQ-SF, The International Physical Activity Questionnaire - Short Form\n",
      "- DHQ, Diet Habits Questionnaire\n",
      "Study Name: An Online Educational Course for People with MS: A randomised controlled trial of course effectiveness\n",
      "Protocol Number: 1\n",
      "Version & date: Version 3, dated 13 December 2021\n",
      "- SCQ, Self-administered Comorbidity Questionnaire\n",
      "- MSPSS, Multidimensional Scale of Perceived Social Support\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life-54\n",
      "- FSS, Fatigue Severity Scale\n",
      "- HADS, Hospital Anxiety and Depression Scale\n",
      "- PDDS, Patient-Determined Disease Steps\n",
      "- UWSE survey, University of Washington Self-Efficacy survey\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life 54\n",
      "- PHC, Physical Health Composite\n",
      "- MHC, Mental Health Composite\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "There are no validated clinical questionnaires mentioned in the text. The text describes a randomized controlled trial of an online educational course for people with MS, which includes an integrated lifestyle modification program with seven modules. The study will use qualitative interviewing to assess the effectiveness of the course. The text does not mention any specific questionnaires used in the trial.\n",
      "- IPAQ-SF, International Physical Activity Questionnaire Short Form\n",
      "- MAQ, Meditation Assessment Questionnaire\n",
      "- DHQ, Diet History Questionnaire\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- MSQOL-54, Health-related quality of life: MS Quality of Life 54 questionnaire\n",
      "- PDDS, Patient-determined disease steps\n",
      "- HADS, Hospital Anxiety and Depression Scale\n",
      "- FSS, Fatigue Severity Scale\n",
      "- UWSE-6, Generalized Self-Efficacy Scale\n",
      "- No other validated clinical questionnaires were found in the text.\n",
      "- MSQOL-54, Multiple Sclerosis Quality of Life 54-item survey\n",
      "- FSS, Fatigue Severity Scale\n",
      "- HADS, Hospital Anxiety and Depression Scale\n",
      "- UWSE, University of Washington Self-Efficacy Scale\n",
      "There are no validated clinical questionnaires mentioned in this text.\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- DHQ, Dietary Habits Questionnaire\n",
      "- HADS, Hospital Anxiety and Depression\n",
      "- UWSE-6, University of Washington Self-Efficacy Scale\n",
      "- MSPSS, Multidimensional Scale of Perceived Social Support\n",
      "- MSQOL54.pdt, Multiple Sclerosis Quality of Life-54\n",
      "- FSS, Fatigue Severity Scale Questionnaire\n",
      "- Neuro-QoL, Quality of Life in Neurological Disorders\n",
      "- IPAQ, International Physical Activity Questionnaire\n",
      "- PARADISE-24, Psychological And Reactivation and Distress In MS - 24 questionnaire\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- FCBP, Females of childbearing potential\n",
      "- FDA, Food and Drug Administration\n",
      "- Fatigue Severity Scale\n",
      "- Mindfulness Adherence Questionnaire\n",
      "- NARCOMS registry: fatigue assessment\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- MS Invigor8\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- Diet Habits Questionnaire\n",
      "- Self-Administered Comorbidity Questionnaire\n",
      "- Stress Management for MS\n",
      "- Mindfulness-Based Stress Reduction\n",
      "- Vitamin D Supplements Use\n",
      "- Behavioral Nutrition Interventions\n",
      "- Body Mass Index\n",
      "- Interpreting the significance of changes in health-related quality-of-life scores\n",
      "- Impact of mindful-based stress reduction for people with multiple sclerosis\n",
      "- Higher quality diet and non-consumption of meat\n",
      "- Australian standard classification of cultural and ethnic groups\n",
      "- Self-administered comorbidity questionnaire\n",
      "- The perceived benefits and barriers to exercise participation\n",
      "- Health-related quality of life and symptom research in glioblastoma multiforme patients\n",
      "- Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis\n",
      "- Stress management interventions for multiple sclerosis\n",
      "- DLQI, Dermatology Life Quality Index\n",
      "- EQ-5D, European Quality of Life 5-Dimension Questionnaire\n",
      "- FCBP, Females of childbearing potential\n",
      "- FDA, Food and Drug Administration\n"
     ]
    }
   ],
   "source": [
    "for answer in answers:\n",
    "    print(answer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "processed = []\n",
    "for answer in my_answers:\n",
    "    if not answer == 'No validated clinical questionnaires were used in this text.' and not answer == 'None':\n",
    "        temp = answer.replace('\\n', '')\n",
    "        temp1 = temp.replace('The validated clinical questionnaires used in this text are', '')\n",
    "        temp2 = temp1.replace('The validated clinical questionnaires used in this text', '')\n",
    "        temp3 = temp2.replace('Validated clinical questionnaires used in this text', '')\n",
    "        temp4 = temp3.strip(':-').strip('- ')\n",
    "        temp5 = temp4.strip('There are no validated clinical questionnaires are used in this text.')\n",
    "        processed.append(temp5)\n",
    "    \n",
    "processed = list(filter(None, processed))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018)\n",
      "Australian Code for the Responsible Conduct of Research, 2018 (the Code)\n",
      "Note for Guidance on Good Clinical Practice (CPMP/ICH-135/95)\n",
      "MSQOL-54, validated tool designed to measure HRQOL in people with MS\n",
      "['PROTOCOL', 'An Online Educational Course for People with MS: A randomised', 'controlled trial of course effectiveness', 'Protocol Number: #1', 'Version: #3', 'Date: 13/12/2021', 'Author/s:', 'Dr Sandra Neate', 'Dr Jeanette Reece', 'Mr Will Bevens', 'Ms Maggie Yu', 'Dr Steve Simpson-Yap', 'Sponsor/s:', 'None', 'CONFIDENTIAL', 'This document is confidential and the property of The University of Melbourne. No part of it may', 'be transmitted, reproduced, published, or used without prior written authorization from the', 'institution.', 'Statement of Compliance', 'This study will be conducted in compliance with all stipulation of this protocol, the conditions of', 'the ethics committee approval, the NHMRC National Statement on ethical Conduct in Human', 'Research (2007 updated 2018). Australian Code for the Responsible Conduct of', 'Research, 2018 (the Code) and the principles of the Note for Guidance on Good Clinical', 'Practice (CPMP/ICH-135/95).']\n",
      "MSQOL-54, Multiple Sclerosis Quality of Life-54 instrum\n",
      "IPAQ-SF, International Physical Activity Questionnaire - Short Form\n",
      "FSS, Fatigue Severity S\n",
      "MAQ, Mindfulness Adherence Q\n",
      "PDDS, Patient-Determined Disease Step\n",
      "PHC, Physical Health Comp\n",
      "MHC, Mental Health Comp\n",
      "MSPSS, Multidimensional Scale of Perceived Social Supp\n",
      "UWSE, University of Washington Self-Efficacy\n",
      "Diet Habits Q\n",
      "NEU Multiple Sclerosis Online Course (MSOC)\n",
      "Dermatology Life Quality Index (DLQI)\n",
      "European Quality of Life 5-Dimension Questionnaire (EQ-5D)\n",
      "IPAQ-SF, The International Physical Activity Questionnaire - Short Form\n",
      "DHQ, Diet Habits Q\n",
      "Study Name: An Online Educational Course for People with MS: A randomised controlled trial of course eff\n",
      "Protocol Number: 1\n",
      "Version & date: Version 3, dated 13 December 2021\n",
      "SCQ, Self-administered Comorbidity Q\n",
      "MSPSS, Multidimensional Scale of Perceived Social Supp\n",
      "MSQOL-54, Multiple Sclerosis Quality of Life-54\n",
      "FSS, Fatigue Severity S\n",
      "HADS, Hospital Anxiety and Depression S\n",
      "PDDS, Patient-Determined Disease Step\n",
      "UWSE survey, University of Washington Self-Efficacy survey\n",
      "MSQOL-54, Multiple Sclerosis Quality of Life 54\n",
      "EQ-5D, European Quality of Life 5-Dimension Q\n",
      "DLQI, Dermatology Life Quality I\n",
      "mentioned in the text. The text describes a randomized controlled trial of an online educational course for people with MS, which includes an integrated lifestyle modification program with seven modules. The study will use qualitative interviewing to assess the effectiveness of the course. The text does not mention any specif\n",
      "IPAQ-SF, International Physical Activity Questionnaire Short Form\n",
      "MAQ, Meditation Assessment Q\n",
      "DHQ, Diet History Q\n",
      "MSQOL-54, Health-related quality of life: MS Quality of Life 54\n",
      "PDDS, Patient-determined disease step\n",
      "UWSE-6, Generalized Self-Efficacy S\n",
      "No other validated clinical questionnaires were f\n",
      "MSQOL-54, Multiple Sclerosis Quality of Life 54-item survey\n",
      "UWSE, University of Washington Self-Efficacy S\n",
      "m\n",
      "DHQ, Dietary Habits Q\n",
      "HADS, Hospital Anxiety and Dep\n",
      "UWSE-6, University of Washington Self-Efficacy S\n",
      "MSQOL54.pdt, Multiple Sclerosis Quality of Life-54\n",
      "FSS, Fatigue Severity Scale Q\n",
      "Neuro-QoL, Quality of Life in Neurological D\n",
      "IPAQ, International Physical Activity Q\n",
      "PARADISE-24, Psychological And Reactivation and Distress In MS - 24\n",
      "FCBP, Females of childbearing p\n",
      "FDA, Food and Drug Adm\n",
      "Fatigue Severity S\n",
      "Mindfulness Adherence Q\n",
      "NARCOMS registry: fatigue assessm\n",
      "MS Invigor8\n",
      "Self-Administered Comorbidity Q\n",
      "Stress Management for MS\n",
      "Mindfulness-Based Stress R\n",
      "Vitamin D Supplements U\n",
      "Behavioral Nutrition I\n",
      "Body Mass I\n",
      "Interpreting the significance of changes in health-related quality-of-lif\n",
      "Impact of mindful-based stress reduction for people with multip\n",
      "Higher quality diet and non-consumption of m\n",
      "Australian standard classification of cultural and ethnic group\n",
      "Self-administered comorbidity\n",
      "perceived benefits and barriers to exercise particip\n",
      "Health-related quality of life and symptom research in glioblastoma multiforme p\n",
      "Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multip\n",
      "Stress management interventions for multip\n"
     ]
    }
   ],
   "source": [
    "for answer in processed:\n",
    "    print(answer)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "EQ-5D, European Quality of Life 5-Dimension Q\n",
    "DLQI, Dermatology Life Quality I\n",
    "PGI-S, Patient Global Impression of Severity\n",
    "PGI-C, Patient Global Impression of Chang\n",
    "SF-36, Short Form 36\n",
    "EQ-5D-5L, EuroQol 5 Dimension 5 Level Health Utility I\n",
    "EQ-VAS, EuroQol Visual Analogue S\n",
    "WPAI-ANS-CPV, Work Productivity and Activity Impairment Q\n",
    "CKD-AQ, Symptoms of aCKD\n",
    "CKD-AQ, Chronic Kidney Disease - Anemia Q\n",
    "SF-36, Short Form 36 Health Survey\n",
    "EQ-5D, European Quality of Life 5-Dimension Q\n",
    "WPAI-ANS-CPV, Work Productivity and Activity Impairment - Anemia Short Form\n",
    "KDOQI, Kidney Disease Outcomes Quality I\n",
    "CKD-EPI, CKD Epidemiology Collab\n",
    "Levey, 2009\n",
    "Answ\n",
    "PGI-S, Patient Global Impression of Severity\n",
    "PGI-C, Patient Global Impression of Chang\n",
    "SF-36, Health Related Quality of Lif\n",
    "EQ-5D-5L, EuroQol 5 Dimension 5 Level Health Utility I\n",
    "EQ-VAS, EuroQol Visual Analogue S\n",
    "WPAI-ANS-CPV, Work Productivity and Activity Impairment Questionnaire for the specific health problem of anemia, Clinical Practice Version 2.0\n",
    "SF-36 Vitality scale,\n",
    "SF-36 Subscales,\n",
    "EuroQol 5 Dimension 5 Level Health Utility Index,\n",
    "EuroQol Visual Analogue Scale,\n",
    "Chronic Kidney Disease - Anemia Q\n",
    "WPAI-ANS-CPV, Work Productivity and Activity Impairment Questionnaire: Anemic Symptoms Clinical Practice V\n",
    "SF-36, Short Form -36\n"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "chatgpt\n",
    "SF-36, 36-item Short Form Health Survey Vitality dom\n",
    "EQ-5D, European Quality of Life 5-Dimension Q\n",
    "DLQI, Dermatology Life Quality I\n",
    "EQ-5D-5L, EuroQol 5 Dimension 5 Level Health Utility I\n",
    "DLQI, Dermatology Life Quality I\n",
    "PGI-S, Patient Global Impression of Severity\n",
    "PGI-C, Patient Global Impression of Chang\n",
    "CKD-AQ8, Symptoms of aCKD\n",
    "SF-36, Short Form 36\n",
    "EQ-VAS, EuroQol Visual Analogue S\n",
    "WPAI-ANS-CPV, Work Productivity and Activity Impairment Q\n",
    "CKD-AQ, Chronic Kidney Disease - Anemia Q\n",
    "EQ-5D-5L, European Quality of Life 5-Dimension 5-Level Q\n",
    "SF-36, Short Form-36 Health Survey\n",
    "WPAI-ANS-CPV, Work Productivity and Activity Impairment - Allergy Specific and Child Productivity and Activity Impairment Q\n",
    "KDOQI CKD stages 3, 4 or 5, Kidney Disease Outcomes Quality I\n",
    "HemoCue Hgb, Stab\n",
    "Females of childbearing potential (FCBP)\n",
    "Hemocue Hgb\n",
    "IV\n",
    "O\n",
    "FDA, Food and Drug Adm\n",
    "There are no validated clinical questionnaires mentioned in the p\n",
    "There are no validated clinical questionnaires mentioned in the g\n",
    "CKD-AQ, Chronic Kidney Disease - Anemia Q\n",
    "SF-36, Health Related Quality of Lif\n",
    "EQ-5D-5L, Health S\n",
    "EQ-VAS, EuroQol Visual Analogue S\n",
    "WPAI-ANS-CPV, Work Productivity and Activity Impairment Questionnaire for the specific health problem of anemia, Clinical Practice Version 2.0\n",
    "SF-36, Short Form Health Survey\n",
    "EQ-5D-5L, EuroQol 5 Dimension 5 Level Health Utility I\n",
    "WPAI-ANS-CPV, Work Productivity and Activity Impairment Questionnaire: Anemic Symptoms Clinical Practice V\n",
    "SF-36, Short Form -36\n",
    "PGI-C, Patient Global Impression of Chang\n",
    "PGI-S, Patient Global Impression of Severity\n",
    "There are no validated clinical questionnaires m\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.1"
  },
  "orig_nbformat": 4,
  "vscode": {
   "interpreter": {
    "hash": "9464ac5cfb2010fde3ae7f0d3430beeb41c2cace6af57bfda8f8d5420c56c15e"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
